335: A deep dive on Makary, Vertex's pain data, & 2025 predictions
Dec 19, 2024•34 min
Episode description
STAT's FDA reporter Lizzy Lawrence joins us to discuss her profile of Marty Makary, Trump's nominee for FDA commissioner. Then, we discuss the results of Vertex's latest pain drug trial, the medication launches to watch in 2025, and present our burning questions for the biopharma industry.
For the best experience, listen in Metacast app for iOS or Android
